ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Research Report 2026
Published Date: 2026-02-03
|
Report Code: QYRE-Auto-27S18256
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global PMO Phosphorodiamidate Morpholino Oligomers Drug Market Research Report 2024
BUY CHAPTERS

Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Research Report 2026

Code: QYRE-Auto-27S18256
Report
2026-02-03
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sarepta Therapeutics Inc
NS Pharma Inc
Nippon Shinyaku
Dyne
Avidity Biosciences

PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market

The global PMO (Phosphorodiamidate Morpholino Oligomers) Drug market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The advantage of PMO drugs is that they can regulate target genes at two levels: splicing conversion and translation level blocking. Currently, they are mostly used to treat Duchenne muscular dystrophy.
The North American market for PMO (Phosphorodiamidate Morpholino Oligomers) Drug is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for PMO (Phosphorodiamidate Morpholino Oligomers) Drug is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for PMO (Phosphorodiamidate Morpholino Oligomers) Drug in Hospital is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of PMO (Phosphorodiamidate Morpholino Oligomers) Drug include Sarepta Therapeutics, Inc, NS Pharma, Inc., Nippon Shinyaku, Dyne, Avidity Biosciences, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global PMO (Phosphorodiamidate Morpholino Oligomers) Drug market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding PMO (Phosphorodiamidate Morpholino Oligomers) Drug. The PMO (Phosphorodiamidate Morpholino Oligomers) Drug market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global PMO (Phosphorodiamidate Morpholino Oligomers) Drug market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist PMO (Phosphorodiamidate Morpholino Oligomers) Drug manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Report

Report Metric Details
Report Name PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market
Segment by Type
  • DMD exon 51 Based
  • DMD exon 53 Based
  • DMD exon 45 Based
  • Other
Segment by Application
  • Hospital
  • Clinic
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sarepta Therapeutics, Inc, NS Pharma, Inc., Nippon Shinyaku, Dyne, Avidity Biosciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for PMO (Phosphorodiamidate Morpholino Oligomers) Drug companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market report?

Ans: The main players in the PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market are Sarepta Therapeutics, Inc, NS Pharma, Inc., Nippon Shinyaku, Dyne, Avidity Biosciences

What are the Application segmentation covered in the PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market report?

Ans: The Applications covered in the PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market report are Hospital, Clinic

What are the Type segmentation covered in the PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market report?

Ans: The Types covered in the PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market report are DMD exon 51 Based, DMD exon 53 Based, DMD exon 45 Based, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 DMD exon 51 Based
1.2.3 DMD exon 53 Based
1.2.4 DMD exon 45 Based
1.2.5 Other
1.3 Market by Application
1.3.1 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Perspective (2021–2032)
2.2 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Growth Trends by Region
2.2.1 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 PMO (Phosphorodiamidate Morpholino Oligomers) Drug Historic Market Size by Region (2021–2026)
2.2.3 PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecasted Market Size by Region (2027–2032)
2.3 PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Dynamics
2.3.1 PMO (Phosphorodiamidate Morpholino Oligomers) Drug Industry Trends
2.3.2 PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Drivers
2.3.3 PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Challenges
2.3.4 PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PMO (Phosphorodiamidate Morpholino Oligomers) Drug Players by Revenue
3.1.1 Global Top PMO (Phosphorodiamidate Morpholino Oligomers) Drug Players by Revenue (2021–2026)
3.1.2 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue Market Share by Players (2021–2026)
3.2 Global Top PMO (Phosphorodiamidate Morpholino Oligomers) Drug Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue
3.4 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Concentration Ratio
3.4.1 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue in 2025
3.5 Global Key Players of PMO (Phosphorodiamidate Morpholino Oligomers) Drug Head Offices and Areas Served
3.6 Global Key Players of PMO (Phosphorodiamidate Morpholino Oligomers) Drug, Products and Applications
3.7 Global Key Players of PMO (Phosphorodiamidate Morpholino Oligomers) Drug, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 PMO (Phosphorodiamidate Morpholino Oligomers) Drug Breakdown Data by Type
4.1 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Historic Market Size by Type (2021–2026)
4.2 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecasted Market Size by Type (2027–2032)
5 PMO (Phosphorodiamidate Morpholino Oligomers) Drug Breakdown Data by Application
5.1 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Historic Market Size by Application (2021–2026)
5.2 Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size (2021–2032)
6.2 North America PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Country (2021–2026)
6.4 North America PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size (2021–2032)
7.2 Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Country (2021–2026)
7.4 Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size (2021–2032)
8.2 Asia-Pacific PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Region (2021–2026)
8.4 Asia-Pacific PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size (2021–2032)
9.2 Latin America PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Country (2021–2026)
9.4 Latin America PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size (2021–2032)
10.2 Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Country (2021–2026)
10.4 Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sarepta Therapeutics, Inc
11.1.1 Sarepta Therapeutics, Inc Company Details
11.1.2 Sarepta Therapeutics, Inc Business Overview
11.1.3 Sarepta Therapeutics, Inc PMO (Phosphorodiamidate Morpholino Oligomers) Drug Introduction
11.1.4 Sarepta Therapeutics, Inc Revenue in PMO (Phosphorodiamidate Morpholino Oligomers) Drug Business (2021–2026)
11.1.5 Sarepta Therapeutics, Inc Recent Development
11.2 NS Pharma, Inc.
11.2.1 NS Pharma, Inc. Company Details
11.2.2 NS Pharma, Inc. Business Overview
11.2.3 NS Pharma, Inc. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Introduction
11.2.4 NS Pharma, Inc. Revenue in PMO (Phosphorodiamidate Morpholino Oligomers) Drug Business (2021–2026)
11.2.5 NS Pharma, Inc. Recent Development
11.3 Nippon Shinyaku
11.3.1 Nippon Shinyaku Company Details
11.3.2 Nippon Shinyaku Business Overview
11.3.3 Nippon Shinyaku PMO (Phosphorodiamidate Morpholino Oligomers) Drug Introduction
11.3.4 Nippon Shinyaku Revenue in PMO (Phosphorodiamidate Morpholino Oligomers) Drug Business (2021–2026)
11.3.5 Nippon Shinyaku Recent Development
11.4 Dyne
11.4.1 Dyne Company Details
11.4.2 Dyne Business Overview
11.4.3 Dyne PMO (Phosphorodiamidate Morpholino Oligomers) Drug Introduction
11.4.4 Dyne Revenue in PMO (Phosphorodiamidate Morpholino Oligomers) Drug Business (2021–2026)
11.4.5 Dyne Recent Development
11.5 Avidity Biosciences
11.5.1 Avidity Biosciences Company Details
11.5.2 Avidity Biosciences Business Overview
11.5.3 Avidity Biosciences PMO (Phosphorodiamidate Morpholino Oligomers) Drug Introduction
11.5.4 Avidity Biosciences Revenue in PMO (Phosphorodiamidate Morpholino Oligomers) Drug Business (2021–2026)
11.5.5 Avidity Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Sarepta Therapeutics Inc
NS Pharma Inc
Nippon Shinyaku
Dyne
Avidity Biosciences
List of Tables
 Table 1. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of DMD exon 51 Based
 Table 3. Key Players of DMD exon 53 Based
 Table 4. Key Players of DMD exon 45 Based
 Table 5. Key Players of Other
 Table 6. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Region (US$ Million), 2021–2026
 Table 9. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Share by Region (2021–2026)
 Table 10. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Share by Region (2027–2032)
 Table 12. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Trends
 Table 13. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Drivers
 Table 14. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Challenges
 Table 15. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Restraints
 Table 16. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue by Players (US$ Million), 2021–2026
 Table 17. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Share by Players (2021–2026)
 Table 18. Global Top PMO (Phosphorodiamidate Morpholino Oligomers) Drug Players by Tier (Tier 1, Tier 2, and Tier 3), based on PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue, 2025
 Table 19. Ranking of Global Top PMO (Phosphorodiamidate Morpholino Oligomers) Drug Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of PMO (Phosphorodiamidate Morpholino Oligomers) Drug, Headquarters and Area Served
 Table 22. Global Key Players of PMO (Phosphorodiamidate Morpholino Oligomers) Drug, Products and Applications
 Table 23. Global Key Players of PMO (Phosphorodiamidate Morpholino Oligomers) Drug, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Type (US$ Million), 2021–2026
 Table 26. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue Market Share by Type (2021–2026)
 Table 27. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue Market Share by Type (2027–2032)
 Table 29. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Application (US$ Million), 2021–2026
 Table 30. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue Market Share by Application (2021–2026)
 Table 31. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue Market Share by Application (2027–2032)
 Table 33. North America PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Country (US$ Million), 2021–2026
 Table 35. North America PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Country (US$ Million), 2027–2032
 Table 48. Sarepta Therapeutics, Inc Company Details
 Table 49. Sarepta Therapeutics, Inc Business Overview
 Table 50. Sarepta Therapeutics, Inc PMO (Phosphorodiamidate Morpholino Oligomers) Drug Product
 Table 51. Sarepta Therapeutics, Inc Revenue in PMO (Phosphorodiamidate Morpholino Oligomers) Drug Business (US$ Million), 2021–2026
 Table 52. Sarepta Therapeutics, Inc Recent Development
 Table 53. NS Pharma, Inc. Company Details
 Table 54. NS Pharma, Inc. Business Overview
 Table 55. NS Pharma, Inc. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Product
 Table 56. NS Pharma, Inc. Revenue in PMO (Phosphorodiamidate Morpholino Oligomers) Drug Business (US$ Million), 2021–2026
 Table 57. NS Pharma, Inc. Recent Development
 Table 58. Nippon Shinyaku Company Details
 Table 59. Nippon Shinyaku Business Overview
 Table 60. Nippon Shinyaku PMO (Phosphorodiamidate Morpholino Oligomers) Drug Product
 Table 61. Nippon Shinyaku Revenue in PMO (Phosphorodiamidate Morpholino Oligomers) Drug Business (US$ Million), 2021–2026
 Table 62. Nippon Shinyaku Recent Development
 Table 63. Dyne Company Details
 Table 64. Dyne Business Overview
 Table 65. Dyne PMO (Phosphorodiamidate Morpholino Oligomers) Drug Product
 Table 66. Dyne Revenue in PMO (Phosphorodiamidate Morpholino Oligomers) Drug Business (US$ Million), 2021–2026
 Table 67. Dyne Recent Development
 Table 68. Avidity Biosciences Company Details
 Table 69. Avidity Biosciences Business Overview
 Table 70. Avidity Biosciences PMO (Phosphorodiamidate Morpholino Oligomers) Drug Product
 Table 71. Avidity Biosciences Revenue in PMO (Phosphorodiamidate Morpholino Oligomers) Drug Business (US$ Million), 2021–2026
 Table 72. Avidity Biosciences Recent Development
 Table 73. Research Programs/Design for This Report
 Table 74. Key Data Information from Secondary Sources
 Table 75. Key Data Information from Primary Sources
 Table 76. Authors List of This Report


List of Figures
 Figure 1. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Picture
 Figure 2. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Share by Type: 2025 vs 2032
 Figure 4. DMD exon 51 Based Features
 Figure 5. DMD exon 53 Based Features
 Figure 6. DMD exon 45 Based Features
 Figure 7. Other Features
 Figure 8. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Share by Application: 2025 vs 2032
 Figure 10. Hospital Case Studies
 Figure 11. Clinic Case Studies
 Figure 12. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Report Years Considered
 Figure 13. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Share by Region: 2025 vs 2032
 Figure 16. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Share by Players in 2025
 Figure 17. Global PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by PMO (Phosphorodiamidate Morpholino Oligomers) Drug Revenue in 2025
 Figure 19. North America PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Share by Country (2021–2032)
 Figure 21. United States PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Share by Country (2021–2032)
 Figure 25. Germany PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Share by Region (2021–2032)
 Figure 33. China PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Share by Country (2021–2032)
 Figure 41. Mexico PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Share by Country (2021–2032)
 Figure 45. Israel PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE PMO (Phosphorodiamidate Morpholino Oligomers) Drug Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Sarepta Therapeutics, Inc Revenue Growth Rate in PMO (Phosphorodiamidate Morpholino Oligomers) Drug Business (2021–2026)
 Figure 49. NS Pharma, Inc. Revenue Growth Rate in PMO (Phosphorodiamidate Morpholino Oligomers) Drug Business (2021–2026)
 Figure 50. Nippon Shinyaku Revenue Growth Rate in PMO (Phosphorodiamidate Morpholino Oligomers) Drug Business (2021–2026)
 Figure 51. Dyne Revenue Growth Rate in PMO (Phosphorodiamidate Morpholino Oligomers) Drug Business (2021–2026)
 Figure 52. Avidity Biosciences Revenue Growth Rate in PMO (Phosphorodiamidate Morpholino Oligomers) Drug Business (2021–2026)
 Figure 53. Bottom-up and Top-down Approaches for This Report
 Figure 54. Data Triangulation
 Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Trimethyl Phosphate TMPO Market Research Report 2024
Global Peptide PMO Conjugates PPMO Market Research Report 2024
Global N N Dimorpholinomethane Market Research Report 2025
Global Morpholine Market Research Report 2024
Global N 3 Aminopropyl Morpholine Market Insights Forecast to 2030
Global 2 Morpholinoethanol Market Research Report 2024
Global Oligodendroglioma Treatment Market Research Report 2024
Global Poly 4 methyl 1 pentene PMP Market Research Report 2025
Global Adipate Oligomer Market Research Report 2025
Global Phosphodiesterase Inhibitor Market Research Report 2025
Global Glycerylphosphorylcholine API Market Research Report 2025
Global Metachromatic Leukodystrophy MLD Treatment Market Research Report 2024
Global Phosphorodiamidate Morpholino Oligomers PMO Market Research Report 2024
Global PMO Monomer Market Research Report 2024
Metaraminol Bitartrate API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global PMO Conjugates Market Research Report 2024
Global Oculopharyngeal Muscular Dystrophy OPMD Drugs Market Research Report 2025
Global Amyloid Oligomer Market Research Report 2024
Global Pharmaceutical Grade L a Glycerophosphorylcholine Market Research Report 2025
Global Pharmaceutical Grade L a Glycerophosphorylcholine Powder Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions